VI
OM icon

Versor Investments’s Outset Medical OM Stock Holding History

Versor Investments’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,053
Closed -$172K – 820
2023
Q3 		$172K Buy
+1,053
New +$249K 0.03% 605
2022
Q3 		– Sell
-797
Closed -$178K – 905
2022
Q2 		$178K Buy
+797
New +$343K 0.01% 753

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Versor Investments's OM Position: Q4 2023 in Review

Versor Investments sold out of Outset Medical (OM) in Q4 2023, closing a stake of 1,053 shares — an estimated $172K sold.

Versor Investments first reported a position in OM in Q2 2022 and held it in 2 quarters. The position peaked at $178K in Q2 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Versor Investments reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Versor Investments sold 1,053 Outset Medical shares in Q4 2023, an estimated $172K.
  • Versor Investments first reported a position in Outset Medical in Q2 2022 and held it in 2 quarters.
  • Versor Investments's Outset Medical position peaked at $178K in Q2 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Versor Investments's 13F filing for Q4 2023, filed 7 Feb 2024.